December 29, 2017 – Moncton, NB - Organigram Holdings Inc. -
(TSXV:OGI)(OTCQB:OGRMF) (“Organigram” or the “Company”) announces that it
has issued an aggregate of 40,000 incentive stock options to Derrick West a director of the
Company, at an exercise price of $3.70 per share.
All of the above-mentioned options have been granted pursuant to the Company’s Stock
Option Plan which has been previously approved by the Company’s shareholders and the
TSX Venture Exchange. In accordance with the Plan, all such options shall expire 10 years
after issuance.
For more information, visit www.organigram.ca
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly
owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada.
Organigram is focused on producing the highest quality, condition specific medical
marijuana for patients in Canada. Organigram's facility is located in Moncton, New
Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes
Regulations (“ACMPR”).
Organigram has been ranked in the top ten Clean Technology & Life Sciences Sector on
the TSX Venture Exchange 50.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is
defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy
or accuracy of this release.
This news release contains forward-looking information which involves known and
unknown risks, uncertainties and other factors that may cause actual events to differ
materially from current expectations. Important factors - including the availability of funds,
consummation of definitive documentation, the results of financing efforts, crop yields -
that could cause actual results to differ materially from the Company's expectations are
disclosed in the Company's documents filed from time to time on SEDAR (see
www.sedar.com). Readers are cautioned not to place undue reliance on these forwardlooking statements, which speak only as of the date of this press release. The Company
disclaims any intention or obligation, except to the extent required by law, to update or
revise any forward-looking statements, whether as a result of new information, future
events or otherwise.
For further information, please contact: